Adviser Profile
|
Exempt Reporting Adviser
2B(1)-VC
|
|
| Private Fund GAV* | 0 |
| SMA’s | No |
| Private Funds | 0 |
Private Funds
Employees
Top Holdings
| Stock Ticker | Stock Name | $ Position | % Position | $ Change | # Change |
|---|---|---|---|---|---|
| Stck Ticker89532M101 | Stock NameTrevi Therapeutics, Inc. | $ Position$246,594,552 | % Position16.00% | $ Change56.00% | # Change0.00% |
| Stck Ticker55287L101 | Stock NameMBX Biosciences, Inc. | $ Position$199,519,627 | % Position13.00% | $ Change85.00% | # Change0.00% |
| Stck Ticker61225M102 | Stock NameMonte Rosa Therapeutics, Inc. | $ Position$186,153,612 | % Position12.00% | $ Change47.00% | # Change0.00% |
| Stck Ticker15102K100 | Stock NameCelcuity Inc. | $ Position$178,958,892 | % Position11.00% | $ Change-31.00% | # Change-25.00% |
| Stck Ticker85220G109 | Stock NameSpyglass Pharma, Inc. | $ Position$164,552,620 | % Position10.00% | $ Change-14.00% | # Change0.00% |
| Stck Ticker805111101 | Stock NameSavara, Inc. | $ Position$150,742,986 | % Position9.00% | $ Change13.00% | # Change0.00% |
| Stck Ticker98937L105 | Stock NameZenas BioPharma, Inc. | $ Position$102,109,298 | % Position6.00% | $ Change30.00% | # Change0.00% |
| Stck Ticker22266M104 | Stock NameCoursera, Inc. | $ Position$72,574,217 | % Position5.00% | $ Change-3.00% | # Change0.00% |
| Stck TickerH17182108 | Stock NameCRISPR Therapeutics AG | $ Position$57,734,408 | % Position4.00% | $ Change15.00% | # Change0.00% |
| Stck Ticker05156V102 | Stock NameAurinia Pharmaceuticals, Inc. | $ Position$67,368,083 | % Position4.00% | $ Change15.00% | # Change0.00% |